Lipoprotein(a), Homocysteine, and Retinal Arteriosclerosis

Overview

Journal Mol Vis

Specialties Cell Biology
Molecular Biology
Ophthalmology

Date 2008 Sep 23

PMID 18806883

Citations 8

Authors

Amir Ghorbanihaghjo

Alireza Javadzadeh

Hassan Argani

Nariman Nezami

Nadereh Rashtchizadeh

Mandana Rafeey

Mohammad Rohbaninoubar

Babak Rahimi-Ardabili

Affiliations

Soon will be listed here.

Abstract

Purpose: Elevated levels of lipoprotein(a) [Lp(a)] and homocysteine (Hcy) have been implicated as risk factors for vascular diseases. The study was performed to explore the possible relationship between retinal arteriosclerosis and serum Lp(a) and Hcy levels.

Methods: Study subjects consisted of 80 nonsmoking male patients with retinal arteriosclerosis and 54 healthy nonsmoker males as controls. Retinal arteriosclerosis was graded according to the Scheie classification. Serum levels of lipids, lipoproteins, Lp(a), and Hcy were measured by standard methods.

Results: The serum level of Hcy was higher in patients (24.2+/-8.1 micromol/l) than controls (10.5+/-4.1 micromol/l); p<0.01. Serum levels of Lp(a) in patients (47.9+/-33.1 mg/dl) was also higher than controls (11.7+/-7.6 mg/dl); p<0.01. There was a significant direct linear correlation between the degree of retinal arteriosclerosis and Lp(a) level (r=0.61, p<0.01), the degree of retinal arteriosclerosis and Hcy level (r=0.72, p<0.01), and also between Lp(a) and Hcy levels (r=0.67, p<0.01).

Conclusions: The association between retinal arteriosclerosis and serum Lp(a) and Hcy levels suggests that Lp(a) as well as Hcy could play a role in the development of retinal arteriosclerosis.

Citing Articles

A Comprehensive Health Screening Program Reveals the Prevalence of and Risk Factors for Age-Related Macular Degeneration: A Cross-Sectional Analysis.

Ma D, Oh B, Bak E, Kim J, Lee J, Choi H Biomedicines. 2025; 12(12.

PMID: 39767587 PMC: 11727633. DOI: 10.3390/biomedicines12122681.

Rebuilding Microbiome for Mitigating Traumatic Brain Injury: Importance of Restructuring the Gut-Microbiome-Brain Axis.

George A, Behera J, Homme R, Tyagi N, Tyagi S, Singh M Mol Neurobiol. 2021; 58(8):3614-3627.

PMID: 33774742 PMC: 8003896. DOI: 10.1007/s12035-021-02357-2.

Implication of Hyperhomocysteinemia in Blood Retinal Barrier (BRB) Dysfunction.

Tawfik A, Samra Y, Elsherbiny N, Al-Shabrawey M Biomolecules. 2020; 10(8).

PMID: 32751132 PMC: 7463551. DOI: 10.3390/biom10081119.

Association Between Folic Acid Supplementation and Retinal Atherosclerosis in Chinese Adults With Hypertension Complicated by Diabetes Mellitus.

Meng Y, Li J, Chen X, She H, Zhao L, Peng Y Front Pharmacol. 2018; 9:1159.

PMID: 30425639 PMC: 6218923. DOI: 10.3389/fphar.2018.01159.

Hyperhomocysteinemia Alters Retinal Endothelial Cells Barrier Function and Angiogenic Potential via Activation of Oxidative Stress.

Mohamed R, Sharma I, Ibrahim A, Saleh H, Elsherbiny N, Fulzele S Sci Rep. 2017; 7(1):11952.

PMID: 28931831 PMC: 5607263. DOI: 10.1038/s41598-017-09731-y.

References

FRIEDEWALD W, Levy R, Fredrickson D . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502. View

den Heijer M, Koster T, Blom H, Bos G, Briet E, Reitsma P . Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 1996; 334(12):759-62. DOI: 10.1056/NEJM199603213341203. View

Zorio E, Falco C, Arnau M, Espana F, Osa A, Ramon L . Lipoprotein (a) in young individuals as a marker of the presence of ischemic heart disease and the severity of coronary lesions. Haematologica. 2006; 91(4):562-5. View

Baldassarre D, Tremoli E, Franceschini G, Michelagnoli S, Sirtori C . Plasma lipoprotein(a) is an independent factor associated with carotid wall thickening in severely but not moderately hypercholesterolemic patients. Stroke. 1996; 27(6):1044-9. DOI: 10.1161/01.str.27.6.1044. View

Teikari J, Laatikainen L, Rapola J, Virtamo J, Haukka J, Liesto K . Retinal vascular changes following supplementation with alpha-tocopherol or beta-carotene. Acta Ophthalmol Scand. 1998; 76(1):68-73. DOI: 10.1034/j.1600-0420.1998.760112.x. View

De Cree C, MALINOW M, van Kranenburg G, Geurten P, Longford N, Keizer H . Influence of exercise and menstrual cycle phase on plasma homocyst(e)ine levels in young women--a prospective study. Scand J Med Sci Sports. 1999; 9(5):272-8. DOI: 10.1111/j.1600-0838.1999.tb00245.x. View

Boushey C, Beresford S, Omenn G, Motulsky A . A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 1995; 274(13):1049-57. DOI: 10.1001/jama.1995.03530130055028. View

Leung H, Wang J, Rochtchina E, Tan A, Wong T, Klein R . Relationships between age, blood pressure, and retinal vessel diameters in an older population. Invest Ophthalmol Vis Sci. 2003; 44(7):2900-4. DOI: 10.1167/iovs.02-1114. View

Berg G, Mesch V, Boero L, Sayegh F, Prada M, Royer M . Lipid and lipoprotein profile in menopausal transition. Effects of hormones, age and fat distribution. Horm Metab Res. 2004; 36(4):215-20. DOI: 10.1055/s-2004-814450. View

10.

Yung L, Leung F, Yao X, Chen Z, Huang Y . Reactive oxygen species in vascular wall. Cardiovasc Hematol Disord Drug Targets. 2006; 6(1):1-19. DOI: 10.2174/187152906776092659. View

11.

Martin S, Rauz S, Marr J, Martin N, Jones A, Dodson P . Plasma total homocysteine and retinal vascular disease. Eye (Lond). 2000; 14 ( Pt 4):590-3. DOI: 10.1038/eye.2000.148. View

12.

Wong T, Klein R, Klein B, Tielsch J, Hubbard L, Nieto F . Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality. Surv Ophthalmol. 2001; 46(1):59-80. DOI: 10.1016/s0039-6257(01)00234-x. View

13.

Morita Y, Himeno H, Yakuwa H, Usui T . Serum lipoprotein(a) level and clinical coronary stenosis progression in patients with myocardial infarction: re-revascularization rate is high in patients with high-Lp(a). Circ J. 2006; 70(2):156-62. DOI: 10.1253/circj.70.156. View

14.

Sandholzer C, Saha N, Kark J, Rees A, Jaross W, Dieplinger H . Apo(a) isoforms predict risk for coronary heart disease. A study in six populations. Arterioscler Thromb. 1992; 12(10):1214-26. DOI: 10.1161/01.atv.12.10.1214. View

15.

HARPEL P, Chang V, Borth W . Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism. Proc Natl Acad Sci U S A. 1992; 89(21):10193-7. PMC: 50304. DOI: 10.1073/pnas.89.21.10193. View

16.

Foody J, Milberg J, Robinson K, Pearce G, Jacobsen D, Sprecher D . Homocysteine and lipoprotein(a) interact to increase CAD risk in young men and women. Arterioscler Thromb Vasc Biol. 2000; 20(2):493-9. DOI: 10.1161/01.atv.20.2.493. View

17.

HARPEL P, Zhang X, Borth W . Homocysteine and hemostasis: pathogenic mechanisms predisposing to thrombosis. J Nutr. 1996; 126(4 Suppl):1285S-9S. DOI: 10.1093/jn/126.suppl_4.1285S. View

18.

SCHEIE H . Evaluation of ophthalmoscopic changes of hypertension and arteriolar sclerosis. AMA Arch Ophthalmol. 1953; 49(2):117-38. DOI: 10.1001/archopht.1953.00920020122001. View

19.

Maioli M, Tonolo G, Pacifico A, Ciccarese M, Brizzi P, Kohner E . Raised serum apolipoprotein (a) in active diabetic retinopathy. Diabetologia. 1993; 36(1):88-90. DOI: 10.1007/BF00399100. View

20.

Discepolo W, Wun T, Berglund L . Lipoprotein(a) and thrombocytes: potential mechanisms underlying cardiovascular risk. Pathophysiol Haemost Thromb. 2006; 35(3-4):314-21. DOI: 10.1159/000093224. View